Drug Trial Radar · NCT01988428
Prehospital Antibiotics Against Sepsis Trial
Last checked: Nov 19, 2026Latest source record: Jun 15, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
2,672
Actual
Start
Jun 2014
Primary completion
Jun 2017
Study completion Jun 2017
Sponsor
- Lead sponsor
- Amsterdam UMC, location VUmcAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Stichting Nuts Ohra; Nederlandse Internisten Vereniging ( Dutch Association of Internists)
- First posted
- Nov 20, 2013
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Sepsis is one of the most frequent reasons for referral to emergency departments (EDs) worldwide. The incidence of sepsis is likely to rise in the upcoming years. Sepsis has a tendency to become more serious when left untreated with a high mortality rate, exceeding even those of myocardial infarction and stroke. Therefore, much effort has been put in to start with appropriate therapy as early as possible. Early goal-directed therapy (EGDT) in the emergency department with fluid resuscitation, administration of vasopressors/vasodilators and intravenous antibiotics in patients with severe sepsis and septic shock has indeed decreased mortality substantially. Emergency medical services (EMS) personnel have already made a significant difference in improving care for patients with acute coronary syndrome, multiple trauma and stroke. Patients with severe sepsis or septic shock could also benefit greatly from timely pre-hospital care. Earlier recognition and initiation of treatment by EMS personnel may improve survival even more. Interestingly, the first hour of ED presentation seems to be the most critical hour. Administration of antibiotics and fluid resuscitation in the pre-hospital setting will reduce the time to administration substantially. In adults, to the best of our knowledge, no studies on the effect of pre-hospital administration of antibiotics have been performed. In children with meningitis, some uncontrolled studies show contradictory results, most probably due to bias by severity. We propose a non-blinded randomised multicentre clinical trial study on the efficacy of early, pre-hospital intravenous administration of broad spectrum antibiotics (ceftriaxone), which are effective against a wide variety of infectious pathogens that cause most common community-acquired infections) in patients referred to the ED with suspected severe sepsis or septic shock. Objective: To evaluate whether early, pre-hospital administration of antibiotics, together with training of ambulance personnel in recognizing and initiating treatment reduces 28-day mortality in patients referred to the ED with suspected severe sepsis or septic shock Study design: Non-blinded randomized multicentre clinical trial nested within a stepped wedge design Study population: All patients above the age of 18 years, with suspected severe sepsis or septic shock and transferred to the ED by ambulance, are eligible for study inclusion Intervention: prehospital antibiotics (ceftriaxone 2000 mg intravenously) Main study parameters/endpoints: 28-day mortality, hospital length of stay, admission to intensive or medium care unit (ICU/MC), time to administration of antibiotics. Follow up of one year. QoL after one month after discharge.
Conditions
- Sepsis
- Severe Sepsis
- Septic Shock
Interventions
Ceftriaxone 2000 mgDrug
Ceftriaxone 2000 mg
Primary outcomes
What the sponsor says the trial is designed to measure.
- mortalityTime frame: 28 day mortality
Locations
34 sites in 1 country. Site status is shown where the registry gives one.
Meander Medical Center
Amersfoort, Netherlands
Academic Medical Centre
Amsterdam, Netherlands
BovenIJ hospital
Amsterdam, Netherlands
Onze Lieve Vrouwe Gasthuis Oost (former: St. Lucas Andreas Hospital)
Amsterdam, Netherlands
Onze Lieve Vrouwe Gasthuis Oost
Amsterdam, Netherlands
VU medical center
Amsterdam, Netherlands
Rijnstate Hospital
Arnhem, Netherlands
Rode Kruis Hospital
Beverwijk, Netherlands
Amphia Hospital
Breda, Netherlands
Albert Schweitzer Hospital
Dordrecht, Netherlands
Gelderse Vallei
Ede, Netherlands
Catharina Hospital
Eindhoven, Netherlands
Maxima Medical Center
Eindhoven, Netherlands
St.Anna Hospital
Geldrop, Netherlands
Zuyderland Hospital
Geleen, Netherlands
Beatrix Hospital
Gorinchem, Netherlands
Spaarne Gasthuis, Haarlem
Haarlem, Netherlands
Zuyderland Hospital
Heerlen, Netherlands
Elkerliek Hospital
Helmond, Netherlands
Spaarne Gasthuis
Hoofddorp, Netherlands
Maastricht Medical Center
Maastricht, Netherlands
St.Antonius Hospital
Nieuwegein, Netherlands
Canisius Wilhemina Hospital
Nijmegen, Netherlands
Bravis Hospital
Roosendaal, Netherlands
Haven Hospital
Rotterdam, Netherlands
Ikazia Hospital
Rotterdam, Netherlands
Maasstad Hospital
Rotterdam, Netherlands
St.Franciscus Gasthuis
Rotterdam, Netherlands
Vlietland Hospital
Schiedam, Netherlands
Rivierenland Hospital
Tiel, Netherlands
Diakonesse Hospital
Utrecht, Netherlands
University Medical Center, Utrecht
Utrecht, Netherlands
VieCuri Medical Center
Venlo, Netherlands
Amstelland Ziekenhuis
Amstelveen, North Holland, Netherlands
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.